Placental DNA methylation changes associated with maternal prepregnancy BMI and gestational weight gain
- 18 February 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in International Journal of Obesity
- Vol. 44 (6), 1406-1416
- https://doi.org/10.1038/s41366-020-0546-2
Abstract
Background Maternal obesity prior to or during pregnancy influences fetal growth, predisposing the offspring to increased risk for obesity across the life course. Placental epigenetic mechanisms may underlie these associations. We conducted an epigenome-wide association study to identify placental DNA methylation changes associated with maternal prepregnancy body mass index (BMI) and rate of gestational weight gain at first (GWG1), second (GWG2), and third trimester (GWG3). Method Participants of the NICHD Fetal Growth Studies with genome-wide placental DNA methylation (n = 301) and gene expression (n = 75) data were included. Multivariable-adjusted regression models were used to test the associations of 1 kg/m2 increase in prepregnancy BMI or 1 kg/week increase in GWG with DNA methylation levels. Genes harboring top differentially methylated CpGs (FDR P < 0.05) were evaluated for placental gene expression. We assessed whether DNA methylation sites known to be associated with BMI in child or adult tissues, were also associated with maternal prepregnancy BMI in placenta. Results Prepregnancy BMI was associated with DNA methylation at cg14568196[EGFL7], cg15339142[VETZ], and cg02301019[AC092377.1] (FDR P < 0.05, P ranging from 1.4 × 10−10 to 1.7 × 10−9). GWG1 or GWG2 was associated with DNA methylation at cg17918270[MYT1L], cg20735365[DLX5], and cg17451688[SLC35F3] (FDR P < 0.05, P ranging from 6.4 × 10−10 to 1.2 × 10−8). Both prepregnancy BMI and DNA methylation at cg1456819 [EGFL7] were negatively correlated with EGFL7 expression in placenta (P < 0.05). Several CpGs previously implicated in obesity traits in children and adults were associated with prepregnancy BMI in placenta. Functional annotations revealed that EGFL7 is highly expressed in placenta and the differentially methylated CpG sites near EGFL7 and VEZT were cis-meQTL targets in blood. Conclusions We identified placental DNA methylation changes at novel loci associated with prepregnancy BMI and GWG. The overlap between CpGs associated with obesity traits in placenta and other tissues in children and adults suggests that epigenetic mechanisms in placenta may give insights to early origins of obesity.Keywords
This publication has 59 references indexed in Scilit:
- A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation dataBioinformatics, 2012
- The sva package for removing batch effects and other unwanted variation in high-throughput experimentsBioinformatics, 2012
- Using DNA Methylation to Understand Biological Consequences of Genetic VariabilityNeurodegenerative Diseases, 2012
- Birthweight, Maternal Weight Trajectories and Global DNA Methylation of LINE-1 Repetitive ElementsPLOS ONE, 2011
- Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysisBMC Bioinformatics, 2010
- Differential expression analysis for sequence count dataGenome Biology, 2010
- Nuclear Orphan Receptor TAK1/TR4-Deficient Mice Are Protected Against Obesity-Linked Inflammation, Hepatic Steatosis, and Insulin ResistanceDiabetes, 2010
- Review: The Placenta is a Programming Agent for Cardiovascular DiseasePlacenta, 2010
- Molecular Mechanisms of Hepatic Steatosis and Insulin Resistance in the AGPAT2-Deficient Mouse Model of Congenital Generalized LipodystrophyCell Metabolism, 2009
- Vezatin, a ubiquitous protein of adherens cell–cell junctions, is exclusively expressed in germ cells in mouse testisReproduction, 2007